Evidence map›Paper›PMID 41039861›Full record

ArticleThe Journal of neuropsychiatry and clinical neurosciences2026

Erica Cotton, Kristen Mordecai, Laura McWhirter, Veronica Cabreira, Ryan Van Patten, Noah Silverberg, Aaron Kaat, W Curt LaFrance

Abstract read
In one paragraph

Article in The Journal of neuropsychiatry and clinical neurosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Erica CottonDepartment of Psychiatry and Behavioral Sciences and Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago.
Kristen MordecaiNeuropsychology Section, Veterans Affairs Maryland Health Care System, Baltimore.
Laura McWhirterCenter for Clinical Brain Sciences, Royal Infirmary of Edinburgh, Edinburgh.
Veronica CabreiraCenter for Clinical Brain Sciences, Royal Infirmary of Edinburgh, Edinburgh.
Ryan Van PattenCenter for Neurorestoration and Neurotechnology, Providence Veterans Affairs Medical Center, and Department of Psychiatry and Human Behavior, Brown University, Providence, RI.ORCID 0000-0002-6203-6688
Noah SilverbergDepartment of Psychology, University of British Columbia, Vancouver.
Aaron KaatDepartment of Medical Social Sciences (Outcome and Measurement Science), Northwestern University, Evanston, IL.
W Curt LaFranceCenter for Neurorestoration and Neurotechnology, Providence Veterans Affairs Medical Center, and Department of Psychiatry and Human Behavior, Brown University, Providence, RI.ORCID 0000-0002-4901-3852

Funding

Treatments for Psychogenic Nonepileptic Seizures (NES)K23NS045902 · NINDS · RHODE ISLAND HOSPITAL (PROVIDENCE, RI) · PI LAFRANCE, W CURT · 2003 to 2007
$818k
Intramural VA VA999999NINDS NIH HHS K23 NS045902
6 · The paper itself

Abstract

objectiveFunctional cognitive disorder (FCD) is a subtype of functional neurological disorder (FND). FCD may include various cognitive symptoms, precipitants, and comorbid conditions (such as other FNDs, concussion, fatigue, or fibromyalgia). However, no widely available behavioral health interventions exist for FCD. The authors developed a therapist-guided and patient-led treatment for veterans and civilians with FCD.

methodsA well-known evidence-based treatment for functional seizures (an FCD-adjacent condition often with cognitive symptoms) was adapted to fit hypothesized mechanisms of FCD. The process used a health research format following the guidance for reporting intervention development studies. Key processes included determining the broad intervention framework, obtaining detailed FCD-specific content based on expert consensus, collecting evidence, developing theory, conducting target population-centered approaches, considering specialty subgroups, and gathering feedback from veteran and civilian stakeholders.

resultsThe authors created a comprehensive 14-chapter manualized therapist-guided neurobehavioral therapy protocol for FCD symptoms independent of etiology, the

conclusionsThis promising new multimodality behavioral health intervention can be considered to be in stage 1 (i.e., intervention generation, refinement, modification, adaptation, and pilot testing). Further pilot testing is being conducted and will need to be followed by traditional efficacy testing (in stage 2).

Indexed as

Cognition DisordersCognitive DysfunctionConversion DisorderAdultFemaleHumansMaleMiddle AgedVeteransCognitive DisordersFunctional Cognitive DisorderFunctional Neurological DisorderNeurobehavioral Therapy ProtocolSomatoform Disorders

Identifiers

PMID41039861
PMCPMC12810142

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.